Global cancer incidence over four years increased by 11% to an estimated 14.1 million cases.
Los Angeles, CA (PRWEB) February 04, 2015
As a single entity, cancer is the biggest cause of mortality worldwide. Each year over 12.7 million people undergo cancer diagnosis and 8.2 million people die from the disease. It is one of the leading causes of death in Australia with an estimated 43,700 people succumbing each year, in spite of a 30% improvement in survival over the last two decades. In 2014, about 128,290 Australians are expected to be diagnosed with cancer (72,110 men and 56,180 women) and an estimated 149,990 are expected to be diagnosed in 2020. The annual cost of treating cancer in Australia is more than $2 billion. Cancer, which is now the third leading cause of death in the UAE, is causing 10% of all deaths in 2010 and 16% of all deaths in the emirate of Abu Dhabi during the same year. Lung cancer is the most common cancer amongst Emirates males but is extremely rare in females, which reflects the prevalence of smoking (23.0% vs. 0.5%, respectively), and colorectal cancer is the second most common cancer. Cervical cancer is the third most commonly diagnosed cancer and the fourth leading cause of cancer death in females’ worldwide, accounting for 9% (529,800) of the total new cancer cases and 8% (275,100) of the total cancer deaths among females.
Various Cancer Conferences organized by OMICS International across USA, Spain, UAE and Australia will be a small contribution towards the cancer awareness and cancer research. These events are expected to attract renowned Scientists, Researchers, Seasonal Academicians, Post Doc’s scholars, Students, Business delegates and esteemed top management representing industries. Oncology Events is characterized by the presence of renowned Oncologists, Radiologists, Chemotherapists, medical practitioners and clinicians and students as well as business professionals creating an atmosphere conducive for collaborations and scientific associations.
The total global annual market for next generation cancer diagnostics was $776 million in 2010, and is growing at a compound annual growth rate (CAGR) of 47%, to reach a forecast market size of $5.3 billion in 2015. The global cancer/tumor profiling market was valued at $13.30 billion in 2012. At the end of 2013, the market was $14.99 billion and is poised to reach around $35 billion by 2018, growing at a CAGR of 18.50% from 2013 to 2018.
OMICS Medical Conference calendar accommodate 300 International symposiums and workshops which are arranged parallel to the scientific-sessions where issues are discussed around a single topic related to the conference main theme. Prostate cancer, today the most common tumor in men, has an increasingly favorable prognosis, with a global survival rate of 76%, which is higher in young adults.
OMICS Group organizes more than 1000 scientific events every year across USA, Europe, Middle East and Asia. These conferences create a venue to connect and share recent research, knowledge and development in various fields, involving established researchers, scientists, entrepreneurs and students. B2B and Scientific meetings organized by us are excellent platform for networking and business development. OMICS International has an enhanced and highlighted feature of scientific partnerships and alliances with development agencies, Institutes, leading research organizations, non-government organizations, and other entities to promote the development-oriented research across the globe. It has collaborated with more than 1000 Scientific Associations and institutions worldwide to promote information on health care through more than 500 leading-edged, Peer reviewed, Open Access Journals. These journals have over 5 million readers and backup of 30000 eminent personalities providing rapid, quality and quick reviews.